TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharma Nord Norge AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
4,448
|
2,960
|
3,350 |
| Financial expenses |
6
|
2
|
2 |
| Earnings before taxes |
274
|
178
|
98 |
| Total assets |
1,647
|
1,220
|
1,735 |
| Current assets |
1,514
|
1,071
|
1,565 |
| Current liabilities |
1,544
|
1,114
|
1,616 |
| Equity capital |
93
|
96
|
106 |
| - share capital |
84
|
89
|
95 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
5.6%
|
7.9%
|
6.1% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
6.2%
|
6.0%
|
2.9% |
| Return on assets (ROA) |
17.0%
|
14.8%
|
5.8% |
| Current ratio |
98.1%
|
96.1%
|
96.8% |
| Return on equity (ROE) |
294.6%
|
185.4%
|
92.5% |
| Change turnover |
1,639
|
-177
|
-370 |
| Change turnover % |
58%
|
-6%
|
-10% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.